Factors that Influence Prescribers in their Selection and use of COX-2 Selective Inhibitors as Opposed to Non-selective NSAIDs*

被引：0
|
作者：
Anna I. Gunnarsdóttir
Moira Kinnear
机构：
[1] Landspitali-University Hospital,Clinical Pharmacy
[2] University of Strathclyde,Lothian Pharmacy Practice Unit, Edinburgh and Department of Pharmaceutical Sciences
来源：
Pharmacy World and Science | 2005年 / 27卷
关键词：
Case series; COX-2 selective inhibitors; Medical decision making; Non-steroidal anti-inflammatory drugs (NSAIDs); Prescribing; Questionnaire; Scotland;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Objective: To identify factors that influence prescribers in their selection and use of cyclo-oxygenase-2 (COX-2) selective inhibitors as opposed to non-selective non-steroidal anti-inflammatory drugs (NSAIDs) and report the tendency to co-prescribe gastro-protection with these agents.
引用
收藏
页码：316 / 320
页数：4
相关论文
共 50 条
  • [1] Factors that influence prescribers in their selection and use of COX-2 selective inhibitors as opposed to non-selective NSAIDs
    Gunnarsdóttir, AI
    Kinnear, M
    PHARMACY WORLD & SCIENCE, 2005, 27 (04): : 316 - 320
  • [2] Non-selective NSAIDs and COX-2 selective inhibitors: GI risk and use of proton pump inhibitor prophylaxis
    Ofman, JJ
    Badamgarav, E
    Knight, K
    Henning, JM
    Wallace, K
    Wong, J
    Dylan, M
    Laine, L
    GASTROENTEROLOGY, 2003, 124 (04) : A107 - A107
  • [3] COX-2 selective and non-selective NSAIDs and the risk of acute myocardial infarction
    Andersohn, Frank
    Suissa, Samy
    Garbe, Edeltraut
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2006, 15 : S59 - S59
  • [4] Modulation of COX-1 and COX-2 Protein Levels by Selective and Non-Selective NSAIDs
    Schneider, Ryan
    Whited, Tawna
    Adams, Bryce
    Miller, Ian
    Stang, Christopher
    Kim, Lindsay
    Dudley, Richard
    Kinder, David
    FASEB JOURNAL, 2015, 29
  • [5] Disease-modifying effects of COX-2 selective inhibitors and non-selective NSAIDs in osteoarthritis: a systematic review
    Nakata, K.
    Hanai, T.
    Take, Y.
    Osada, T.
    Tsuchiya, T.
    Shima, D.
    Fujimoto, Y.
    OSTEOARTHRITIS AND CARTILAGE, 2018, 26 (10) : 1263 - 1273
  • [6] Survival Analysis of Australian Veterans using COX-2 Selective or Non-Selective NSAIDs
    Kerr, Stephen J.
    Sayer, Geoffrey P.
    Whicker, Susan D.
    Rowett, Debra S.
    Mant, Andrea
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 : S206 - S206
  • [7] Risk of stroke in arthritis patients treated with cox-2 selective and non-selective NSAIDs
    Graham, David J.
    Singh, Gurkirpal
    Wang, H.
    Mannalithara, A.
    Lingala, V.
    Mithal, Alka
    Triadafilopoulos, George
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 : S67 - S67
  • [8] Efficacy of COX-2 selective NSAIDs, non-selective NSAIDs, and acetaminophen in osteoarthritis: A Bayesian mixed treatment comparison
    Jansen, J. P.
    Gaugris, S.
    Stam, W.
    VALUE IN HEALTH, 2008, 11 (03) : A255 - A255
  • [9] NSAIDs: gastroprotection or selective COX-2 inhibitors?
    Davis, MP
    PALLIATIVE MEDICINE, 2005, 19 (02) : 165 - 165
  • [10] Gastrointestinal bleeding associated with of a concurrent utilisation of selective COX-2 inhibitors and aspirin versus non-selective NSAIDs and aspirin
    Rahme, E
    Bardou, M
    Dasgupta, K
    Toubouti, Y
    Ghosn, J
    Barkun, AN
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 522 - 523
12345